Association of Variability and Pharmacogenomics With Bioequivalence of Gefitinib in Healthy Male Subjects

Objective: The aim of the study was to explore the association of pharmacokinetic variability and pharmacogenomics with the bioequivalence of orally administered gefitinib (Iressa®, AstraZeneca) provided by three sponsors in healthy subjects. Methods: The study designs were randomized, open-label, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong, Li, Qingmei, Zhu, Xiaoxue, Wu, Min, Li, Cuiyun, Li, Xiaojiao, Liu, Chengjiao, Shen, Zhenwei, Ding, Yanhua, Hua, Shucheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090208/
https://www.ncbi.nlm.nih.gov/pubmed/30131694
http://dx.doi.org/10.3389/fphar.2018.00849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090208/
https://www.ncbi.nlm.nih.gov/pubmed/30131694
http://dx.doi.org/10.3389/fphar.2018.00849

Ejemplares similares